Pharmaceutical companies stash cash as outlook stays gloomy

Published: 2011-09-22 07:00:00

Updated: 2011-09-22 07:00:00

Publicly held drug firms in Korea are holding sizable amounts of cash – an indication that they are growing more pessimistic over the outlook for future growth, according to Yakup.com.

Yakup.com said that the cash equivalent assets of 51 listed pharmaceutical companies totaled 846.3 billion wo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK